Indonesia Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-monitoring Devices, Continuous Blood Glucose Monitoring Devices), By End Use (Hospitals, Home care, Diagnostic centers), By Procurement, And Segment Forecasts, 2026 - 2033
The Indonesia blood glucose monitoring devices market size was estimated at USD 63.8 million in 2025 and is projected to reach USD 121.0 million by 2033, growing at a CAGR of 7.1% from 2026 to 2033. Market growth is primarily driven by the increasing prevalence of diabetes and growing awareness of the importance of regular glucose monitoring. Recent data shows Indonesia’s diabetes prevalence reaching approximately 11.3% of adults, translating to over 20 million people living with diabetes in 2024, highlighting a substantial target population for monitoring devices. With Indonesia ranking among the countries with the highest diabetes rates in Southeast Asia, the need for reliable self-monitoring of blood glucose levels has become a public health priority.
A major growth driver for the Indonesia blood glucose monitoring devices industry is the government’s intensified focus on diabetes screening and early diagnosis. For instance, in November 2024, Indonesia’s Ministry of Health reinforced its national diabetes prevention strategy by emphasizing regular blood glucose testing and setting a target for 90% of the population, particularly high-risk groups, to receive diabetes screening. The government highlighted that many diabetes cases remain undiagnosed or poorly managed, making early screening and routine glucose checks critical to reducing long-term health complications and healthcare costs. Through expanded screening at community health centers and increased public awareness of healthy lifestyles, the initiative aims to improve early detection, support timely treatment, and reduce the overall economic and healthcare burden of diabetes in Indonesia. These public health strategies are complemented by broader insurance coverage under the JKN national health insurance program, which enhances access to essential health services, including diabetes management tools for a larger segment of the population.
Urbanization and lifestyle shifts further contribute to market growth in Indonesia. Rapid growth in urban centers, such as Java’s Jakarta, Surabaya, and Bandung, has led to increased consumption of processed foods and reduced physical activity, factors associated with a higher prevalence of Type 2 diabetes and a greater reliance on self-monitoring devices. Indonesia’s children, adolescents, and adults continue to follow poor dietary patterns, marked by high consumption of foods and beverages rich in fat, sugar, and salt. At the same time, intake of fruits and vegetables remains low. Around two-thirds of children aged 5-19 years and adults consume at least one sugar-sweetened beverage daily, and nearly 90-95% of the population does not meet the recommended intake levels of fruits and vegetables, which increases long-term metabolic health risks. These unhealthy eating habits are expected to drive higher diabetes prevalence, thereby strengthening the need for regular blood glucose monitoring and sustained demand for glucose monitoring devices across Indonesia. Moreover, the growing middle-class population and increasing smartphone penetration are supporting the adoption of more advanced, connected glucose monitors that integrate with digital health platforms. While affordability and rural healthcare access gaps remain challenges, ongoing public health efforts and technological adoption continue to reinforce market expansion.
Indonesia Blood Glucose Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at the country level and analyzes the latest industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the Indonesia blood glucose monitoring devices market report based on product, end use, and procurement:
A major growth driver for the Indonesia blood glucose monitoring devices industry is the government’s intensified focus on diabetes screening and early diagnosis. For instance, in November 2024, Indonesia’s Ministry of Health reinforced its national diabetes prevention strategy by emphasizing regular blood glucose testing and setting a target for 90% of the population, particularly high-risk groups, to receive diabetes screening. The government highlighted that many diabetes cases remain undiagnosed or poorly managed, making early screening and routine glucose checks critical to reducing long-term health complications and healthcare costs. Through expanded screening at community health centers and increased public awareness of healthy lifestyles, the initiative aims to improve early detection, support timely treatment, and reduce the overall economic and healthcare burden of diabetes in Indonesia. These public health strategies are complemented by broader insurance coverage under the JKN national health insurance program, which enhances access to essential health services, including diabetes management tools for a larger segment of the population.
Urbanization and lifestyle shifts further contribute to market growth in Indonesia. Rapid growth in urban centers, such as Java’s Jakarta, Surabaya, and Bandung, has led to increased consumption of processed foods and reduced physical activity, factors associated with a higher prevalence of Type 2 diabetes and a greater reliance on self-monitoring devices. Indonesia’s children, adolescents, and adults continue to follow poor dietary patterns, marked by high consumption of foods and beverages rich in fat, sugar, and salt. At the same time, intake of fruits and vegetables remains low. Around two-thirds of children aged 5-19 years and adults consume at least one sugar-sweetened beverage daily, and nearly 90-95% of the population does not meet the recommended intake levels of fruits and vegetables, which increases long-term metabolic health risks. These unhealthy eating habits are expected to drive higher diabetes prevalence, thereby strengthening the need for regular blood glucose monitoring and sustained demand for glucose monitoring devices across Indonesia. Moreover, the growing middle-class population and increasing smartphone penetration are supporting the adoption of more advanced, connected glucose monitors that integrate with digital health platforms. While affordability and rural healthcare access gaps remain challenges, ongoing public health efforts and technological adoption continue to reinforce market expansion.
Indonesia Blood Glucose Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at the country level and analyzes the latest industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the Indonesia blood glucose monitoring devices market report based on product, end use, and procurement:
- Product Outlook (Revenue, USD Unit, 2021 - 2033)
- Self-monitoring Devices
- Blood Glucose Meter
- Blood Glucose Meter, by Measurement Technology
- Electrochemical BGMs
- Photometric BGMs
- Blood Glucose Meter, by Data Connectivity
- Non-Connected BGMs
- USB-Connected BGMs
- Bluetooth/Smart BGMs with App and Cloud Integration
- Testing Strips
- Lancets
- Continuous Blood Glucose Monitoring Devices
- Devices
- Consumables
- End Use Outlook (Revenue, USD Unit, 2021 - 2033)
- Hospitals
- Home care
- Diagnostic centers
- Procurement Outlook (Revenue, USD Unit, 2021 - 2033)
- Private
- Government
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.1. Segment Definitions
1.1.1. Product
1.1.2. End Use
1.1.3. Procurement
1.1.4. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. End Use Outlook
2.2.3. Procurement Outlook
2.3. Competitive Insights
CHAPTER 3. INDONESIA BLOOD GLUCOSE MONITORING DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.2.1. High Equipment Costs
3.2.2.2. Limited Accessibility
3.3. Indonesia Blood Glucose Monitoring Devices Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. INDONESIA BLOOD GLUCOSE MONITORING DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Indonesia Blood Glucose Monitoring Devices Market: Product Movement Analysis
4.3. Indonesia Blood Glucose Monitoring Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Self-monitoring Devices
4.5.1. Self-monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Blood Glucose Meter
4.5.2.1. Blood Glucose Meter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.2. Blood Glucose Meter Measurement Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.2.1. Electrochemical BGMs
4.5.2.2.1.1. Electrochemical BGMs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.2.2. Photometric BGMs
4.5.2.2.2.1. Photometric BGMs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3. Blood Glucose Meter Data Connectivity Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3.1. Non-Connected BGMs
4.5.2.3.1.1. Non-Connected BGMs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3.2. USB-Connected BGMs
4.5.2.3.2.1. USB-Connected BGMs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3.3. Bluetooth/Smart BGMs with App and Cloud Integration
4.5.2.3.3.1. Bluetooth/Smart BGMs with App and Cloud Integration Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Testing Strips
4.5.3.1. Testing Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Lancets
4.5.4.1. Lancets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Continuous Blood Glucose Monitoring Devices
4.6.1. Continuous Blood Glucose Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Devices
4.6.2.1. Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Consumables
4.6.3.1. Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 5. INDONESIA BLOOD GLUCOSE MONITORING DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Indonesia Blood Glucose Monitoring Devices Market: End Use Movement Analysis
5.3. Indonesia Blood Glucose Monitoring Devices Market by End Use Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Hospitals
5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Home care
5.6.1. Home Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Diagnostic centers
5.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 6. INDONESIA BLOOD GLUCOSE MONITORING DEVICES MARKET: PROCUREMENT ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Indonesia Blood Glucose Monitoring Devices Market: Procurement Movement Analysis
6.3. Indonesia Blood Glucose Monitoring Devices Market by Procurement Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Private
6.5.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Government
6.6.1. Government Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. PT PHC Indonesia
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. PT. Enseval Medika Prima {Part of Kalbe Farma}
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. PT PJH Manufaktur Indonesia
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. PT. Sentral Medika Indonesia
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. PT Nipro Indonesia Jaya
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Fokus Diagnostic Indonesia
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. PT Elvinco Med. Tech
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Sinocare
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Abbott Laboratories
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Medtronic
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.1. Segment Definitions
1.1.1. Product
1.1.2. End Use
1.1.3. Procurement
1.1.4. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. End Use Outlook
2.2.3. Procurement Outlook
2.3. Competitive Insights
CHAPTER 3. INDONESIA BLOOD GLUCOSE MONITORING DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.2.1. High Equipment Costs
3.2.2.2. Limited Accessibility
3.3. Indonesia Blood Glucose Monitoring Devices Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. INDONESIA BLOOD GLUCOSE MONITORING DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Indonesia Blood Glucose Monitoring Devices Market: Product Movement Analysis
4.3. Indonesia Blood Glucose Monitoring Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Self-monitoring Devices
4.5.1. Self-monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Blood Glucose Meter
4.5.2.1. Blood Glucose Meter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.2. Blood Glucose Meter Measurement Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.2.1. Electrochemical BGMs
4.5.2.2.1.1. Electrochemical BGMs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.2.2. Photometric BGMs
4.5.2.2.2.1. Photometric BGMs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3. Blood Glucose Meter Data Connectivity Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3.1. Non-Connected BGMs
4.5.2.3.1.1. Non-Connected BGMs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3.2. USB-Connected BGMs
4.5.2.3.2.1. USB-Connected BGMs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2.3.3. Bluetooth/Smart BGMs with App and Cloud Integration
4.5.2.3.3.1. Bluetooth/Smart BGMs with App and Cloud Integration Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Testing Strips
4.5.3.1. Testing Strips Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Lancets
4.5.4.1. Lancets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Continuous Blood Glucose Monitoring Devices
4.6.1. Continuous Blood Glucose Monitoring Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Devices
4.6.2.1. Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Consumables
4.6.3.1. Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 5. INDONESIA BLOOD GLUCOSE MONITORING DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Indonesia Blood Glucose Monitoring Devices Market: End Use Movement Analysis
5.3. Indonesia Blood Glucose Monitoring Devices Market by End Use Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Hospitals
5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Home care
5.6.1. Home Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Diagnostic centers
5.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 6. INDONESIA BLOOD GLUCOSE MONITORING DEVICES MARKET: PROCUREMENT ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Indonesia Blood Glucose Monitoring Devices Market: Procurement Movement Analysis
6.3. Indonesia Blood Glucose Monitoring Devices Market by Procurement Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. Private
6.5.1. Private Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Government
6.6.1. Government Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. PT PHC Indonesia
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. PT. Enseval Medika Prima {Part of Kalbe Farma}
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. PT PJH Manufaktur Indonesia
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. PT. Sentral Medika Indonesia
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. PT Nipro Indonesia Jaya
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Fokus Diagnostic Indonesia
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. PT Elvinco Med. Tech
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Sinocare
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Abbott Laboratories
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Medtronic
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Indonesia blood glucose monitoring devices market, by product, 2021 - 2033 (USD Million)
Table 4 Indonesia blood glucose monitoring devices market, by end use, 2021 - 2033 (USD Million)
Table 5 Indonesia blood glucose monitoring devices market, by procurement, 2021 - 2033 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Indonesia blood glucose monitoring devices market, by product, 2021 - 2033 (USD Million)
Table 4 Indonesia blood glucose monitoring devices market, by end use, 2021 - 2033 (USD Million)
Table 5 Indonesia blood glucose monitoring devices market, by procurement, 2021 - 2033 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Indonesia blood glucose monitoring devices: market outlook
Fig. 9 Indonesia blood glucose monitoring devices market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Indonesia blood glucose monitoring devices market driver impact
Fig. 15 Indonesia blood glucose monitoring devices market restraint impact
Fig. 16 Indonesia blood glucose monitoring devices market strategic initiatives analysis
Fig. 17 Indonesia blood glucose monitoring devices market: product movement analysis
Fig. 18 Indonesia blood glucose monitoring devices market: product outlook and key takeaways
Fig. 19 Self-monitoring devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Blood glucose meter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Electrochemical BGMs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Photometric BGMs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Non-connected BGMs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 USB-connected BGMs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Bluetooth/smart BGMs with app and cloud integration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Testing strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Lancets market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Continuous blood glucose monitoring devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Indonesia blood glucose monitoring devices market: end use movement analysis
Fig. 32 Indonesia blood glucose monitoring devices market: end use outlook and key takeaways
Fig. 33 Hospitals’ market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Home care market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Diagnostic centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Indonesia blood glucose monitoring devices market: procurement movement analysis
Fig. 37 Indonesia blood glucose monitoring devices market: procurement outlook and key takeaways
Fig. 38 Private market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Government market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Participant categorization- Indonesia blood glucose monitoring devices market
Fig. 41 Market share of key market players- Indonesia blood glucose monitoring devices market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Indonesia blood glucose monitoring devices: market outlook
Fig. 9 Indonesia blood glucose monitoring devices market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Indonesia blood glucose monitoring devices market driver impact
Fig. 15 Indonesia blood glucose monitoring devices market restraint impact
Fig. 16 Indonesia blood glucose monitoring devices market strategic initiatives analysis
Fig. 17 Indonesia blood glucose monitoring devices market: product movement analysis
Fig. 18 Indonesia blood glucose monitoring devices market: product outlook and key takeaways
Fig. 19 Self-monitoring devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Blood glucose meter market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Electrochemical BGMs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Photometric BGMs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Non-connected BGMs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 USB-connected BGMs market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Bluetooth/smart BGMs with app and cloud integration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Testing strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Lancets market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Continuous blood glucose monitoring devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Indonesia blood glucose monitoring devices market: end use movement analysis
Fig. 32 Indonesia blood glucose monitoring devices market: end use outlook and key takeaways
Fig. 33 Hospitals’ market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Home care market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Diagnostic centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Indonesia blood glucose monitoring devices market: procurement movement analysis
Fig. 37 Indonesia blood glucose monitoring devices market: procurement outlook and key takeaways
Fig. 38 Private market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Government market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Participant categorization- Indonesia blood glucose monitoring devices market
Fig. 41 Market share of key market players- Indonesia blood glucose monitoring devices market
